骨移植片および代用骨：市場洞察・競合情勢・市場予測 (～2032年)

骨移植片および代用骨の市場規模は、2024年の37億8,625万米ドルから、予測期間中はCAGR 5.88％で推移し、2032年には59億5,771万米ドルの規模に成長すると予測されています。

骨に関連する疾患や外傷の有病率の増加と、歯科における骨移植片の需要の高まりが、骨移植片および代用骨の世界市場を大きく押し上げています。骨粗鬆症や骨折などの骨疾患が、特に高齢化社会の中で一般的になるにつれて、効果的な骨再生・修復ソリューションの必要性が急増しています。骨の変性、骨折、関節の問題を起こしやすい老年人口の増加は、特に整形外科手術や歯科手術における骨移植片の需要をさらに押し上げています。さらに、合成、同種移植、異種移植材料における技術革新に伴う製品開発活動の増加が骨移植片の有効性と利用可能性を高めています。2025年から2032年までの予測期間中は、需要の高まりに対応するため、より先進的で生体適合性が高く、費用対効果の高いソリューションが導入される見通しであり、これらの要因が総合的に骨移植片および代用骨の市場拡大に寄与しています。

原料別では、天然移植片の部門が2024年に66.85%のシェアを示し、市場をリードしています。これは、天然移植片が提供する様々な利点や用途が需要を牽引すると考えられています。天然骨移植片は一般的に、ある生物から別の生物に移植される生体組織や骨構造を指し、同じ種、または種を超えて、移植されることもあります。これらの移植片には、骨や軟骨などの組織が含まれます。

これらの骨移植片は生物由来のものであるため、レシピエントの体組織と適合性があります。そのため、拒絶反応のリスクが軽減され、周囲の組織との統合が促進されます。さらに、自家骨移植片や同種骨移植片などの天然骨移植片は、体内に異物を持ち込まないため、合成材料に比べて感染のリスクが低くなります。天然骨移植片は、一度レシピエントの骨組織と一体化すると、長期にわたって強度と支持力を発揮し、治療部位の健康を保証します。

地域別では、北米地域が2024年に47.92%の最大のシェアを占め、2025年から2032年までの予測期間中にCAGR 5.54%で成長すると予測されています。これは、脊椎関連疾患の有病率の増加、歯牙喪失症例の増加に加え、整形外科手術の増加、新製品の発売、研究開発への注力などの要因に起因しています。

当レポートでは、世界の骨移植片および代用骨の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 骨移植片および代用骨市場レポート：イントロダクション

• 調査範囲
• 市場セグメンテーション
• 市場の前提因子

第2章 骨移植片および代用骨市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 骨移植片および代用骨市場：主要要因分析

• 市場促進要因
  • 骨関連疾患および外傷症例の増加
  • 歯科における骨移植の需要増加
  • 増加する高齢者人口
  • 世界での製品開発活動が増加
• 市場抑制要因と課題
  • 大きな骨欠損の治療における限界
  • 自家移植および同種移植に伴うリスク
• 市場機会
  • 合成および天然多孔質代用骨の開発

第6章 骨移植片および代用骨市場：ポーターのファイブフォース分析

第7章 骨移植片および代用骨市場の評価

• 原料別
  • 自然
  • 合成
• 製品タイプ別
  • 同種移植
  • 異種移植
  • その他
• 用途別
  • 頭蓋顎顔面
  • 歯科
  • 関節再建
  • 脊椎固定
• エンドユーザー別
  • 病院・クリニック
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 骨移植片および代用骨市場：企業・製品プロファイル

• Medtronic plc.
• Johnson & Johnson
• Smith & Nephew
• Stryker
• Dentsply Sirona Inc.
• Globus Medical Inc.
• Baxter
• Arthrex, Inc.
• OssDsign
• Orthofix Medical Inc.
• Xtant Medical Holdings, Inc.
• Halma
• B. Braun Melsungen AG
• Exactech Inc. Zimmer Biomet Institute Straumann AG
• Southern Implants
• MedBone Biomaterials
• Noraker
• BioHorizons

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Bone Graft and Substitutes Market in Global (2022-2032)
• Table 3: Bone Graft and Substitutes Market in Global by Source (2022-2032)
• Table 4: Bone Graft and Substitutes Market in Global by Product Type (2022-2032)
• Table 5: Bone Graft and Substitutes Market in Global by Application (2022-2032)
• Table 6: Bone Graft and Substitutes Market in Global by End-User (2022-2032)
• Table 7: Bone Graft and Substitutes Market in Global by Geography (2022-2032)
• Table 8: Bone Graft and Substitutes Market in North America (2022-2032)
• Table 9: Bone Graft and Substitutes Market in the United States (2022-2032)
• Table 10: Bone Graft and Substitutes Market in Canada (2022-2032)
• Table 11: Bone Graft and Substitutes Market in Mexico (2022-2032)
• Table 12: Bone Graft and Substitutes Market in Europe (2022-2032)
• Table 13: Bone Graft and Substitutes Market in France (2022-2032)
• Table 14: Bone Graft and Substitutes Market in Germany (2022-2032)
• Table 15: Bone Graft and Substitutes Market in the United Kingdom (2022-2032)
• Table 16: Bone Graft and Substitutes Market in Italy (2022-2032)
• Table 17: Bone Graft and Substitutes Market in Spain (2022-2032)
• Table 18: Bone Graft and Substitutes Market in the Rest of Europe (2022-2032)
• Table 19: Bone Graft and Substitutes Market in Asia-Pacific (2022-2032)
• Table 20: Bone Graft and Substitutes Market in China (2022-2032)
• Table 21: Bone Graft and Substitutes Market in Japan (2022-2032)
• Table 22: Bone Graft and Substitutes Market in India (2022-2032)
• Table 23: Bone Graft and Substitutes Market in Australia (2022-2032)
• Table 24: Bone Graft and Substitutes Market in South Korea (2022-2032)
• Table 25: Bone Graft and Substitutes Market in Rest of Asia-Pacific (2022-2032)
• Table 26: Bone Graft and Substitutes Market in the Rest of the World (2022-2032)
• Table 27: Bone Graft and Substitutes Market in the Middle East (2022-2032)
• Table 28: Bone Graft and Substitutes Market in Africa (2022-2032)
• Table 29: Bone Graft and Substitutes Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Bone Graft and Substitutes Market in Global (2022-2032)
• Figure 3: Bone Graft and Substitutes Market in Global by Source (2022-2032)
• Figure 4: Bone Graft and Substitutes Market in Global by Product Type (2022-2032)
• Figure 5: Bone Graft and Substitutes Market in Global by Application (2022-2032)
• Figure 6: Bone Graft and Substitutes Market in Global by End-User (2022-2032)
• Figure 7: Bone Graft and Substitutes Market in Global by Geography (2022-2032)
• Figure 8: Bone Graft and Substitutes Market in North America (2022-2032)
• Figure 9: Bone Graft and Substitutes Market in the United States (2022-2032)
• Figure 10: Bone Graft and Substitutes Market in Canada (2022-2032)
• Figure 11: Bone Graft and Substitutes Market in Mexico (2022-2032)
• Figure 12: Bone Graft and Substitutes Market in Europe (2022-2032)
• Figure 13: Bone Graft and Substitutes Market in France (2022-2032)
• Figure 14: Bone Graft and Substitutes Market in Germany (2022-2032)
• Figure 15: Bone Graft and Substitutes Market in the United Kingdom (2022-2032)
• Figure 16: Bone Graft and Substitutes Market in Italy (2022-2032)
• Figure 17: Bone Graft and Substitutes Market in Spain (2022-2032)
• Figure 18: Bone Graft and Substitutes Market in the Rest of Europe (2022-2032)
• Figure 19: Bone Graft and Substitutes Market in Asia-Pacific (2022-2032)
• Figure 20: Bone Graft and Substitutes Market in China (2022-2032)
• Figure 21: Bone Graft and Substitutes Market in Japan (2022-2032)
• Figure 22: Bone Graft and Substitutes Market in India (2022-2032)
• Figure 23: Bone Graft and Substitutes Market in Australia (2022-2032)
• Figure 24: Bone Graft and Substitutes Market in South Korea (2022-2032)
• Figure 25: Bone Graft and Substitutes Market in Rest of Asia-Pacific (2022-2032)
• Figure 26: Bone Graft and Substitutes Market in the Rest of the World (2022-2032)
• Figure 27: Bone Graft and Substitutes Market in the Middle East (2022-2032)
• Figure 28: Bone Graft and Substitutes Market in Africa (2022-2032)
• Figure 29: Bone Graft and Substitutes Market in South America (2022-2032)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Market Opportunities
• Figure 33: PORTER'S Five Force Analysis

Bone Graft and Substitutes Market by Source (Natural and Synthetic), Product Type (Allograft {DBM, BMP, and Cell-Based Matrices}, Xenograft, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spinal Fusion, and Others), End-User (Hospitals & Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of bone-related disorders and trauma cases, rising demand for bone grafts in dentistry, the growing geriatric population, and increase in product development activities across the globe

The bone graft and substitutes market was valued at USD 3,786.25 million in 2024, growing at a CAGR of 5.88% during the forecast period from 2025 to 2032 to reach USD 5,957.71 million by 2032. The increasing prevalence of bone-related disorders and trauma cases, coupled with a rising demand for bone grafts in dentistry, is significantly boosting the global market for bone grafts and substitutes. As bone diseases such as osteoporosis and bone fractures become more common, particularly among the aging population, the need for effective bone regeneration and repair solutions has surged. The growing geriatric population, which is more prone to bone degeneration, fractures, and joint issues, further drives demand for bone grafts, especially in orthopedic and dental procedures. Additionally, the increase in product development activities, with innovations in synthetic, allograft, and xenograft materials, is enhancing the effectiveness and availability of bone graft substitutes. These factors collectively contribute to the expansion of the bone graft and substitutes market, with more advanced, biocompatible, and cost-effective solutions being introduced to meet the rising demand during the forecast period from 2025 to 2032.

Bone Graft and Substitutes Market Dynamics:

As per the International Osteoporosis Foundation (2023), over 8.9 million fractures related to osteoporosis occur annually. Osteoporosis is one of the common degenerative bone diseases where the body starts to lose bone mass or makes too little bone. As individuals with osteoporosis are more prone to fractures, especially in areas like the hip, spine, and wrist, the demand for effective solutions to repair and regenerate damaged bone tissue rises. Bone grafts and substitutes, which are used to promote bone healing and provide structural support, are essential in treating fractures caused by osteoporosis, particularly when fractures are complex or difficult to heal thereby boosting the overall market of bone graft and substitute across the globe.

Moreover, the rising number of trauma cases has also contributed to the rising demand for bone grafts and substitutes. As per the World Health Organization factsheet (2023) on road traffic injuries, road injuries are the leading cause of fatality in children and young adults in the age group 5-29 years. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. In road traffic accidents, the force of impact often leads to complex and severe fractures, including fractures of the limbs, pelvis, spine, and other critical areas, which require immediate and effective treatment. As these injuries often result in substantial bone loss or damage, bone grafts and substitutes become essential for repairing the damaged bones, promoting healing, and ensuring functional recovery.

Another factor contributing to the growth of the bone graft and substitutes market is the rising demand for bone grafts in the dental sector. According to the latest research study "Bone Graft and Substitutes in Dentistry: A Review of Current Trends and Developments" (2021), current estimates suggest that globally, roughly 2.2 million bone transplant surgeries are conducted each year, costing an approximate value of USD 664 million in 2021. The number of surgical procedures for treating bony abnormalities is estimated to grow by approximately 13% yearly.

Additionally, the increase in strategic activities among the key market players is further boosting the market of bone grafts and substitutes across the globe. For instance, in April 2023, ZimVie announced the launches of RegenerOss(R) CC allograft particulate and RegenerOss(R) bone graft plug for filling extraction sockets and periodontal defects.

Thus, the factors mentioned above are expected to boost the overall market of bone grafts and substitutes across the globe during the forecast period from 2025 to 2032.

However, limitations in the management of large bone defects and risks associated with autografts and allografts may hinder the future market of bone grafts and substitutes across the globe during the forecasted period.

Bone Graft and Substitutes Market Segment Analysis:

Bone Graft and Substitutes Market by Source (Natural and Synthetic), Product Type (Allograft {DBM, BMP, and Cell-Based Matrices}, Xenograft, and Others), Application (Craniomaxillofacial, Dental, Joint Reconstruction, Spinal Fusion, and Others), End-User (Hospitals & Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The natural category in the bone graft and substitutes market is estimated to dominate the market with a market share of 66.85% in 2024. This can be attributed to the various advantages and applications provided by grafts taken from natural sources which will be responsible for driving the demand for natural bone grafts and substitutes market during the given forecast period. Natural bone grafts typically refer to biological tissues or bone structures transplanted from one organism to another within the same species or sometimes across species. These grafts include tissues such as bones and cartilage.

These bone grafts are derived from biological sources, making them compatible with the recipient's body tissues. This further reduces the risk of rejection and promotes integration with surrounding tissues. Additionally, natural bone grafts, such as autografts (tissues taken from the patient's own body) or allografts (tissues from a donor of the same species), have a lower risk of infection compared to synthetic materials because they do not introduce foreign substances into the body. Natural bone grafts, once integrated into the recipient's bone tissue, provide long-term strength and support, ensuring the health of the treated area.

Thus, the factors mentioned above are expected to boost the segment thereby boosting the overall market of bone grafts and substitutes across the globe.

North America is expected to dominate the overall bone graft and substitutes market:

Among all regions, North America is estimated to hold the largest share of 47.92% in the global bone graft and substitutes market in 2024, growing at a CAGR of 5.54% during the forecast period from 2025 to 2032. This can be attributed to the growing prevalence of spine-related disorders, and increasing cases of tooth loss, coupled with other supportive factors such as increasing orthopedic surgical procedures, new product launches, and increased focus on research and development among other factors that are driving the overall growth of the bone graft and substitutes market over the forecast period.

As per the data provided by the United Spinal Association (2022), every year approximately 17,700 Americans acquire a spinal cord injury. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happened as a result of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgery (4.3%). Conditions such as degenerative disc disease, spinal deformities, fractures, and spinal stenosis often require surgical interventions, including spinal fusion procedures, to stabilize the spine and alleviate pain. Bone grafts and substitutes are essential in these surgeries to promote bone healing, ensure proper fusion of vertebrae, and restore spinal integrity.

Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), about 1 in 10 adults (11%) aged 65 to 74 years had lost all their teeth. Tooth loss, often caused by periodontal disease, trauma, tooth decay, or aging, results in alveolar bone resorption a condition where the jawbone deteriorates due to the absence of a tooth root to stimulate bone growth. To address this, bone grafts and substitutes are commonly used to regenerate lost bone, providing a stable foundation for dental implants and restoring oral functionality and aesthetics. The rising global prevalence of tooth loss, particularly among the aging population, has created a substantial demand for bone regeneration solutions in dentistry.

Furthermore, the increasing number of product development activities in the region is further going to accelerate the growth of the spinal non-fusion devices market. For instance, in September 2024, Cerapedics Inc., a global orthopedics company focused on improving bone repair treatments, announced that the U.S. Food and Drug Administration (FDA) had approved an expanded use and labeling for its i-FACTOR P-15 Peptide Enhanced Bone Graft. With this approval, i-FACTOR was cleared for use in single-level anterior cervical discectomy fusion (ACDF) procedures. It could be used with an allograft bone ring or combined with a PEEK, titanium alloy, or PEEK/titanium fusion interbody device approved by the FDA for cervical spine use, along with supplemental anterior plate fixation.

Thus, the above-mentioned factors are expected to escalate the market of bone grafts and substitutes in the region.

Bone Graft and Substitutes Market Key Players:

Some of the key market players operating in the bone graft and substitutes market include Medtronic plc., Johnson & Johnson, Smith & Nephew, Stryker, Dentsply Sirona Inc., Globus Medical Inc., Baxter, Arthrex, Inc., OssDsign, Orthofix Medical Inc., Xtant Medical Holdings, Inc., Halma, B. Braun Melsungen AG, Exactech Inc., Zimmer Biomet, Institut Straumann AG, Southern Implants, MedBone Biomaterials, Noraker, BioHorizons, and others.

Recent Developmental Activities in the Bone Graft and Substitutes Market:

• In September 2022, Ivory Dentin Graft, the first and only dentin graft, received CE mark approval.
• In August 2022, Orthofix Medical and CGBio announced the strategic partnership agreement for Novosis rhBMP-2 bone graft solutions.

Key Takeaways From the Bone Graft and Substitutes Market Report Study

• Market size analysis for current bone graft and substitutes size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the bone graft and substitutes market.
• Various opportunities available for the other competitors in the bone graft and substitutes market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current bone graft and substitutes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bone graft and substitute market growth in the coming future?

Target Audience Who Can be Benefited From This Bone Graft and Substitutes Market Report Study

• Bone graft and substitute product providers
• Research organizations and consulting companies
• Bone graft and substitutes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in bone grafts and substitutes
• Various end-users who want to know more about the bone graft and substitutes market and the latest technological developments in the bone graft and substitutes market.

Frequently Asked Questions for the Bone Graft and Substitutes Market:

1. What are bone grafts and substitutes?

• Bone grafts are surgical structures and molds used to replace or augment bone tissues that are missing or damaged. It involves taking bone from one area of the body (autograft), using bone from a donor (allograft), or utilizing synthetic materials (synthetic grafts) to promote bone healing and regeneration.

2. What is the market for bone grafts and substitutes?

• The bone graft and substitutes market was valued at USD 3,786.25 million in 2024, growing at a CAGR of 5.88% during the forecast period from 2025 to 2032 to reach USD 5,957.71 million by 2032.

3. What are the drivers for the global bone graft and substitutes market?

• The increasing prevalence of bone-related disorders and trauma cases, coupled with a rising demand for bone grafts in dentistry, is significantly boosting the global market for bone grafts and substitutes. As bone diseases such as osteoporosis and bone fractures become more common, particularly among the aging population, the need for effective bone regeneration and repair solutions has surged. The growing geriatric population, which is more prone to bone degeneration, fractures, and joint issues, further drives demand for bone grafts, especially in orthopedic and dental procedures. Additionally, the increase in product development activities, with innovations in synthetic, allograft, and xenograft materials, is enhancing the effectiveness and availability of bone graft substitutes. These factors collectively contribute to the expansion of the bone graft and substitutes market, with more advanced, biocompatible, and cost-effective solutions being introduced to meet the rising demand during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global bone graft and substitutes market?

• Some of the key market players operating in the bone graft and substitutes are Medtronic plc., Johnson & Johnson, Smith & Nephew, Stryker, Dentsply Sirona Inc., Globus Medical Inc., Baxter, Arthrex, Inc., OssDsign, Orthofix Medical Inc., Xtant Medical Holdings, Inc., Halma, B. Braun Melsungen AG, Exactech Inc., Zimmer Biomet, Institut Straumann AG, Southern Implants, MedBone Biomaterials, Noraker, BioHorizons, and others.

5. Which region has the highest share in the global bone graft and substitutes market?

• North America region is anticipated to dominate the overall bone graft and substitutes market due to the growing prevalence of spine-related disorders, and increasing cases of tooth loss, coupled with other supportive factors such as increasing orthopedic surgical procedures, new product launches, and increased focus on research and development among other factors that are driving the overall growth of the bone graft and substitutes market over the forecast period.

Table of Contents

1. Bone Graft and Substitutes Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Bone Graft and Substitutes Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Bone Graft and Substitutes Market Key Factors Analysis

• 5.1. Bone Graft and Substitutes Market Drivers
  • 5.1.1. The increasing prevalence of bone-related disorders and trauma cases
  • 5.1.2. Rising demand for bone grafts in dentistry
  • 5.1.3. The growing geriatric population
  • 5.1.4. Increase in product development activities across the globe
• 5.2. Bone Graft and Substitutes Market Restraints and Challenges
  • 5.2.1. Limitations in the management of large bone defects
  • 5.2.2. Risks associated with autografts and allografts
• 5.3. Bone Graft and Substitutes Market Opportunities
  • 5.3.1. Development of Synthetic and Natural Porous Substitutes

6. Bone Graft and Substitutes Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Bone Graft and Substitutes Market Assessment

• 7.1. By Source
  • 7.1.1. Natural
  • 7.1.2. Synthetic
• 7.2. By Product Type
  • 7.2.1. Allograft
    • 7.2.1.1. DBM
    • 7.2.1.2. BMP
    • 7.2.1.3. Cell-Based Matrices
  • 7.2.2. Xenograft
  • 7.2.3. Others
• 7.3. By Application
  • 7.3.1. Craniomaxillofacial
  • 7.3.2. Dental
  • 7.3.3. Joint Reconstruction
  • 7.3.4. Spinal Fusion
  • 7.3.5. Others
• 7.4. By End-User
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.1.2. Canada Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.1.3. Mexico Bone Graft and Substitutes Market Size in USD Million (2022-2032)
  • 7.5.2. Europe
    • 7.5.2.1. France Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2.2. Germany Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2.3. United Kingdom Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2.4. Italy Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2.5. Spain Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.2.6. Rest of Europe Bone Graft and Substitutes Market Size in USD Million (2022-2032)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3.2. Japan Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3.3. India Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3.4. Australia Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3.5. South Korea Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.3.6. Rest of Asia-Pacific Bone Graft and Substitutes Market Size in USD Million (2022-2032)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.4.2. Africa Bone Graft and Substitutes Market Size in USD Million (2022-2032)
    • 7.5.4.3. South America Bone Graft and Substitutes Market Size in USD Million (2022-2032)

8. Bone Graft and Substitutes Market Company and Product Profiles

• 8.1. Medtronic plc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Johnson & Johnson
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Smith & Nephew
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Stryker
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Dentsply Sirona Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Globus Medical Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Baxter
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Arthrex, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. OssDsign
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Orthofix Medical Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Xtant Medical Holdings, Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Halma
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. B. Braun Melsungen AG
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Exactech Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Zimmer Biomet
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Institute Straumann AG
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Southern Implants
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. MedBone Biomaterials
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Noraker
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. BioHorizons
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us